Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

cbdMD, Inc.

YCBD•AMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.92
$-0.03(-3.51%)
U.S. Market opens in 15h 52m

cbdMD, Inc. (YCBD) Stock Overview

Explore cbdMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.5M
P/E Ratio-0.02
EPS (TTM)$-1.09
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$0.51
3 Months$1.42
1 Year Target$0.04

YCBD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of cbdMD, Inc. (YCBD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 9.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.62%
5-Day Change
24.11%
1-Month Change
6.73%
3-Month Change
92.72%
6-Month Change
35.22%
Year-to-Date (YTD) Change
-21.90%
1-Year Change
-73.66%
3-Year Change
-99.04%
5-Year Change
-99.94%
All-Time (Max) Change
-99.95%

Contact Information

https://www.cbdmd.com
704 445 3060
8845 Red Oak Boulevard, Charlotte, NC, 28217

Company Facts

420 Employees
IPO DateNov 17, 2017
CountryUS
Actively Trading

Frequently Asked Questions